ADHD Drug Makers Must Warn Of Side Effects: FDA
The agency said it has directed the manufacturers of all drug products approved for the treatment of ADHD to develop patient medication guides to alert patients to possible cardiovascular risks and risks of adverse psychiatric symptoms associated with the medicines, and to advise them of precautions that can be taken....
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login